Probabilistic bidirectional promoter switches: noncoding RNA takes control.

PubWeight™: 0.79‹?›

🔗 View Article (PMC 4222648)

Published in Mol Ther Nucleic Acids on September 02, 2014

Authors

Stephen K Anderson1

Author Affiliations

1: 1] Basic Science Program, Leidos Biomedical Research Inc; Lab of Experimental Immunology, Frederick National Lab, Frederick, Maryland, USA [2] The Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, USA.

Articles cited by this

NK cell recognition. Annu Rev Immunol (2005) 14.40

MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol (2005) 6.98

An abundance of bidirectional promoters in the human genome. Genome Res (2004) 5.90

MHC class I-specific inhibitory receptors and their ligands structure diverse human NK-cell repertoires toward a balance of missing self-response. Blood (2008) 2.71

RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia. Proc Natl Acad Sci U S A (2013) 2.31

Association of human TFIID-promoter complexes with silenced mitotic chromatin in vivo. Nat Cell Biol (2002) 2.10

Identification of probabilistic transcriptional switches in the Ly49 gene cluster: a eukaryotic mechanism for selective gene activation. Immunity (2004) 2.06

Noncoding transcription at enhancers: general principles and functional models. Annu Rev Genet (2012) 1.98

TBP dynamics in living human cells: constitutive association of TBP with mitotic chromosomes. Mol Biol Cell (2002) 1.78

Crucial role of DNA methylation in determination of clonally distributed killer cell Ig-like receptor expression patterns in NK cells. J Immunol (2002) 1.74

Genetic control of variegated KIR gene expression: polymorphisms of the bi-directional KIR3DL1 promoter are associated with distinct frequencies of gene expression. PLoS Genet (2008) 1.60

Receptor selection in B and T lymphocytes. Annu Rev Immunol (2000) 1.49

Diversity of NK cell receptor repertoire in adult and neonatal mice. J Immunol (1999) 1.37

Taking license with natural killer cell maturation and repertoire development. Immunol Rev (2006) 1.34

Epigenetic control of highly homologous killer Ig-like receptor gene alleles. J Immunol (2005) 1.33

Identification of bidirectional promoters in the human KIR genes. Genes Immun (2007) 1.25

Cutting edge: KIR antisense transcripts are processed into a 28-base PIWI-like RNA in human NK cells. J Immunol (2010) 1.15

Regulation of class I major histocompatibility complex receptor expression in natural killer cells: one promoter is not enough! Immunol Rev (2006) 1.11

The transcription factor c-Myc enhances KIR gene transcription through direct binding to an upstream distal promoter element. Blood (2008) 1.11

Identification of distal KIR promoters and transcripts. Genes Immun (2006) 1.09

Identification of a novel Ly49 promoter that is active in bone marrow and fetal thymus. J Immunol (2002) 1.08

Evidence for epigenetic maintenance of Ly49a monoallelic gene expression. J Immunol (2006) 1.08

Genomic Ly49A transgenes: basis of variegated Ly49A gene expression and identification of a critical regulatory element. J Immunol (2004) 1.05

Ly49 cluster sequence analysis in a mouse model of diabetes: an expanded repertoire of activating receptors in the NOD genome. Genes Immun (2008) 1.00

Direct sequence comparison of two divergent class I MHC natural killer cell receptor haplotypes. Genes Immun (2005) 0.97

Murine cytomegalovirus major immediate-early enhancer region operating as a genetic switch in bidirectional gene pair transcription. J Virol (2007) 0.86

Identification of a KIR antisense lncRNA expressed by progenitor cells. Genes Immun (2013) 0.83

Characterization of a weakly expressed KIR2DL1 variant reveals a novel upstream promoter that controls KIR expression. Genes Immun (2014) 0.83

Deep sequencing reveals a novel class of bidirectional promoters associated with neuronal genes. BMC Genomics (2014) 0.81